Dyes & Pigments · Founded 1986 · www.bodal.com · BSE 524370 · NSE BODAL CHEM · ISIN INE338D01028
No Notes Added Yet
Business
Bodal Chemicals Ltd. is an integrated manufacturer of dyes, dye intermediates, and basic chemicals. The company's core business involves producing a wide range of chemical products used in various industries. It makes money by manufacturing and supplying these specialty and intermediate chemicals to customers primarily in the textile, paper, leather, plastics, paints, and ink industries, both domestically and internationally.
Revenue Mix
Bodal Chemicals primarily operates across three major segments:
Dye Intermediates: These are precursor chemicals used in the production of dyes. This segment typically forms a significant portion of its revenue.
Dyestuffs: The final colored products, including reactive dyes, direct dyes, and acid dyes.
Basic Chemicals: Caustic soda, chlorine, and its derivatives, which are often used internally for backward integration or sold to other industries.
Specific revenue contributions are not provided here to avoid fabrication.
Industry
The Dyes & Pigments industry in India is characterized by a mix of large integrated players and numerous small to medium-sized units. It is sensitive to demand from end-user industries like textiles. Bodal Chemicals is one of India's larger and more integrated manufacturers in the dyes and dye intermediates space, possessing a broad product portfolio and significant production capacities. It competes with both domestic players and international suppliers, often leveraging its cost-efficient manufacturing base in India.
MOAT
Bodal Chemicals' advantages largely stem from:
Backward Integration: Significant integration into key raw materials like basic chemicals (e.g., caustic soda, chlorine) and dye intermediates helps in cost control, supply chain stability, and improved margins compared to non-integrated players.
Scale of Operations: Its relatively large scale allows for economies of scale in manufacturing and procurement, contributing to cost competitiveness.
Product Diversification: A wide range of products across dyes, intermediates, and basic chemicals caters to diverse customer needs and reduces dependence on a single product line or end-use industry.
Growth Drivers
"China+1" Strategy: Global customers seeking to diversify their supply chains away from China could drive increased orders for Indian chemical manufacturers like Bodal.
Demand from End-User Industries: Growth in the textile, paper, construction, and automotive industries (for coatings/paints) will directly impact demand for dyes and chemicals.
Capacity Expansion & Modernization: Investments in increasing production capacity and enhancing manufacturing processes can boost sales volumes and efficiency.
Product Portfolio Enhancement: Focus on developing and manufacturing higher-value specialty chemicals and advanced intermediates can improve margins and market reach.
Increased Domestic Consumption: India's growing economy and consumption patterns support domestic demand for textiles and other end-products.
Risks
Raw Material Price Volatility: Prices of key raw materials (e.g., crude oil derivatives, various chemicals) are subject to global fluctuations, impacting production costs and profitability.
Environmental Regulations: Stringent environmental norms and compliance costs (effluent treatment, waste management) pose ongoing operational and investment challenges.
Intense Competition: The industry faces strong competition, particularly from Chinese manufacturers known for large-scale and cost-effective production.
Forex Fluctuations: As an exporter and importer of raw materials, the company is exposed to currency exchange rate volatility.
Cyclicality of End-User Industries: Demand for its products is tied to the cyclical performance of industries like textiles, leading to potential revenue fluctuations.
Management & Ownership
Bodal Chemicals is a promoter-led company, with significant ownership held by the founding Patel family. Mr. Suresh J. Patel is a prominent figure in the management, having guided the company's growth and integration strategies. The management team has experience in the chemicals sector and has focused on backward integration and capacity expansion.
Outlook
Bodal Chemicals benefits from its integrated operations and diversified product portfolio, positioning it to capitalize on domestic industrial growth and potential global supply chain realignments ("China+1"). Ongoing backward integration efforts could further enhance cost efficiencies and margin stability. However, the company remains exposed to the inherent volatility of a commodity-driven chemical sector, characterized by raw material price fluctuations, environmental compliance costs, and intense competition, which can impact its profitability and financial performance.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 394 | 422 | 432 | 443 | 451 | 454 | 480 | 490 | 588 | 709 |
| Other Income | 5 | 2 | 2 | 2 | 2 | 4 | 20 | 15 | 3 | 6 |
| Total Income | 399 | 424 | 434 | 445 | 453 | 458 | 500 | 505 | 591 | 715 |
| Total Expenditure | 368 | 388 | 396 | 399 | 404 | 407 | 457 | 468 | 519 | 640 |
| Operating Profit | 31 | 37 | 38 | 46 | 50 | 52 | 43 | 37 | 71 | 75 |
| Interest | 16 | 21 | 20 | 20 | 21 | 22 | 20 | 19 | 18 | 19 |
| Depreciation | 17 | 17 | 17 | 17 | 17 | 18 | 17 | 17 | 17 | 17 |
| Exceptional Income / Expenses | 0 | 0 | 0 | -1 | 0 | 0 | -0 | 0 | 0 | 0 |
| Profit Before Tax | -2 | -1 | 1 | 8 | 12 | 13 | 6 | 0 | 36 | 39 |
| Provision for Tax | -4 | -0 | 1 | 3 | -3 | 3 | -0 | -0 | 4 | 9 |
| Profit After Tax | 2 | -1 | -0 | 5 | 15 | 10 | 6 | 0 | 32 | 30 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 2 | -1 | -0 | 5 | 15 | 10 | 6 | 0 | 32 | 30 |
| Adjusted Earnings Per Share | 0.2 | -0.1 | -0 | 0.4 | 1.2 | 0.8 | 0.5 | 0 | 2.5 | 2.4 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 910 | 1234 | 1142 | 1424 | 1375 | 1226 | 2055 | 1574 | 1395 | 1748 | 2012 | 2267 |
| Other Income | 12 | 11 | 9 | 13 | 10 | 16 | 17 | 12 | 25 | 8 | 44 | 44 |
| Total Income | 922 | 1245 | 1152 | 1437 | 1385 | 1242 | 2072 | 1586 | 1420 | 1757 | 2057 | 2311 |
| Total Expenditure | 760 | 1008 | 948 | 1187 | 1237 | 1140 | 1835 | 1441 | 1300 | 1586 | 1854 | 2084 |
| Operating Profit | 162 | 237 | 204 | 249 | 148 | 103 | 237 | 145 | 119 | 171 | 203 | 226 |
| Interest | 12 | 9 | 5 | 9 | 19 | 17 | 29 | 41 | 54 | 82 | 79 | 76 |
| Depreciation | 26 | 29 | 12 | 21 | 28 | 30 | 47 | 53 | 60 | 69 | 70 | 68 |
| Exceptional Income / Expenses | 7 | 5 | 0 | 0 | 0 | 0 | -19 | 0 | 0 | -1 | -0 | 0 |
| Profit Before Tax | 131 | 204 | 186 | 219 | 101 | 55 | 142 | 51 | 5 | 19 | 54 | 81 |
| Provision for Tax | 45 | 71 | 62 | 77 | 15 | 16 | 43 | 13 | -2 | 1 | 7 | 13 |
| Profit After Tax | 86 | 133 | 125 | 142 | 86 | 40 | 99 | 38 | 6 | 19 | 48 | 68 |
| Adjustments | 0 | -0 | -2 | 1 | 1 | 2 | 6 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 86 | 133 | 123 | 143 | 87 | 42 | 104 | 38 | 6 | 19 | 48 | 68 |
| Adjusted Earnings Per Share | 7.9 | 12.2 | 10 | 11.7 | 7.1 | 3.4 | 8.5 | 3 | 0.5 | 1.5 | 3.8 | 5.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 15% | 9% | 10% | 8% |
| Operating Profit CAGR | 19% | 12% | 15% | 2% |
| PAT CAGR | 153% | 8% | 4% | -6% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 156% | 28% | 3% | 1% |
| ROE Average | 4% | 2% | 4% | 15% |
| ROCE Average | 7% | 5% | 6% | 17% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 235 | 363 | 697 | 829 | 931 | 981 | 1052 | 1078 | 1082 | 1105 | 1158 |
| Minority's Interest | 0 | 2 | 1 | 1 | 7 | 5 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 1 | 8 | 1 | 13 | 0 | 106 | 214 | 362 | 443 | 406 | 340 |
| Other Non-Current Liabilities | 15 | 18 | 24 | 36 | 23 | 46 | 43 | 60 | 61 | 61 | 77 |
| Total Current Liabilities | 259 | 316 | 348 | 411 | 495 | 610 | 794 | 621 | 694 | 767 | 760 |
| Total Liabilities | 510 | 707 | 1072 | 1290 | 1455 | 1749 | 2113 | 2120 | 2281 | 2339 | 2336 |
| Fixed Assets | 192 | 222 | 437 | 609 | 656 | 804 | 817 | 967 | 1314 | 1301 | 1239 |
| Other Non-Current Assets | 11 | 80 | 98 | 66 | 41 | 74 | 166 | 302 | 153 | 140 | 163 |
| Total Current Assets | 307 | 405 | 537 | 616 | 758 | 871 | 1122 | 851 | 813 | 898 | 909 |
| Total Assets | 510 | 707 | 1072 | 1290 | 1455 | 1749 | 2113 | 2120 | 2281 | 2339 | 2336 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 0 | 14 | 1 | 8 | 14 | 12 | 9 | 17 | 24 | 23 |
| Cash Flow from Operating Activities | 131 | 104 | 7 | 186 | 10 | -13 | -14 | 290 | 204 | 114 | 176 |
| Cash Flow from Investing Activities | -23 | -68 | -256 | -128 | -81 | -168 | -170 | -310 | -262 | -37 | 11 |
| Cash Flow from Financing Activities | -109 | -23 | 236 | -51 | 76 | 178 | 181 | 33 | 81 | -73 | -191 |
| Net Cash Inflow / Outflow | -1 | 13 | -13 | 7 | 5 | -3 | -3 | 12 | 24 | 3 | -5 |
| Closing Cash & Cash Equivalent | 0 | 14 | 1 | 8 | 14 | 12 | 9 | 17 | 24 | 23 | 17 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 7.88 | 12.18 | 10.03 | 11.72 | 7.13 | 3.43 | 8.51 | 3.03 | 0.51 | 1.47 | 3.8 |
| CEPS(Rs) | 10.24 | 14.83 | 11.19 | 13.38 | 9.35 | 5.74 | 11.86 | 7.25 | 5.32 | 6.91 | 9.33 |
| DPS(Rs) | 0.6 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.1 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 21.5 | 33.24 | 57.01 | 67.73 | 72.52 | 80.05 | 85.83 | 85.68 | 85.96 | 87.72 | 91.91 |
| Core EBITDA Margin(%) | 15.15 | 16.88 | 16.67 | 16.59 | 10.01 | 7.06 | 10.69 | 8.39 | 6.73 | 9.25 | 7.83 |
| EBIT Margin(%) | 14.43 | 15.87 | 16.45 | 16.03 | 8.7 | 5.87 | 8.35 | 5.78 | 4.2 | 5.75 | 6.58 |
| Pre Tax Margin(%) | 13.2 | 15.22 | 15.99 | 15.4 | 7.32 | 4.52 | 6.91 | 3.2 | 0.34 | 1.1 | 2.68 |
| PAT Margin (%) | 8.7 | 9.93 | 10.68 | 9.99 | 6.26 | 3.24 | 4.8 | 2.39 | 0.46 | 1.05 | 2.36 |
| Cash Profit Margin (%) | 11.3 | 12.08 | 11.72 | 11.48 | 8.32 | 5.73 | 7.07 | 5.73 | 4.77 | 4.96 | 5.8 |
| ROA(%) | 16.47 | 21.85 | 14.01 | 12.04 | 6.27 | 2.48 | 5.11 | 1.8 | 0.29 | 0.8 | 2.05 |
| ROE(%) | 43.97 | 44.51 | 23.52 | 18.66 | 10.04 | 4.26 | 9.72 | 3.58 | 0.6 | 1.69 | 4.23 |
| ROCE(%) | 37.18 | 47.7 | 27.56 | 24.3 | 10.94 | 5.49 | 10.85 | 5.15 | 3.09 | 5.06 | 6.71 |
| Receivable days | 67.15 | 54.1 | 90.31 | 86.73 | 104.06 | 137.17 | 93.89 | 115.96 | 104.22 | 81.07 | 75.46 |
| Inventory Days | 30.96 | 30.07 | 38.21 | 41.15 | 56.64 | 78.31 | 66.76 | 84.64 | 72.83 | 62.85 | 59.54 |
| Payable days | 69.46 | 60.36 | 80.41 | 77.03 | 89.22 | 99.21 | 75.7 | 88.21 | 97.29 | 88.92 | 79.42 |
| PER(x) | 9.29 | 13.15 | 12.12 | 10.82 | 5.94 | 26.24 | 11.85 | 19.07 | 142.45 | 39.85 | 13.49 |
| Price/Book(x) | 3.41 | 4.82 | 2.13 | 1.87 | 0.58 | 1.12 | 1.17 | 0.67 | 0.85 | 0.67 | 0.56 |
| Dividend Yield(%) | 0.82 | 0.5 | 0.66 | 0.63 | 1.89 | 0.89 | 0.79 | 0.17 | 0 | 0 | 0 |
| EV/Net Sales(x) | 1.03 | 1.53 | 1.45 | 1.2 | 0.55 | 1.25 | 0.92 | 0.93 | 1.28 | 0.92 | 0.71 |
| EV/Core EBITDA(x) | 5.8 | 7.96 | 8.15 | 6.86 | 5.1 | 15.01 | 8 | 10.12 | 14.95 | 9.42 | 7.02 |
| Net Sales Growth(%) | -12.95 | 35.66 | -7.47 | 24.63 | -3.42 | -10.79 | 67.58 | -23.4 | -11.41 | 25.37 | 15.09 |
| EBIT Growth(%) | -14.28 | 48.9 | -9.76 | 19.01 | -47.57 | -39.8 | 138.12 | -46.44 | -35.79 | 71.05 | 32.02 |
| PAT Growth(%) | -6.31 | 54.59 | -6.27 | 14.12 | -39.49 | -53.78 | 148.1 | -61.45 | -82.99 | 186.01 | 158.5 |
| EPS Growth(%) | -6.31 | 54.57 | -17.66 | 16.84 | -39.2 | -51.84 | 147.96 | -64.42 | -83.01 | 185.65 | 158.49 |
| Debt/Equity(x) | 0.61 | 0.42 | 0.26 | 0.21 | 0.29 | 0.46 | 0.64 | 0.71 | 0.83 | 0.82 | 0.69 |
| Current Ratio(x) | 1.19 | 1.28 | 1.54 | 1.5 | 1.53 | 1.43 | 1.41 | 1.37 | 1.17 | 1.17 | 1.2 |
| Quick Ratio(x) | 0.84 | 0.87 | 1.22 | 0.99 | 1.09 | 0.92 | 0.85 | 0.9 | 0.79 | 0.73 | 0.77 |
| Interest Cover(x) | 11.7 | 24.44 | 36.13 | 25.15 | 6.29 | 4.33 | 5.82 | 2.24 | 1.09 | 1.24 | 1.69 |
| Total Debt/Mcap(x) | 0.18 | 0.09 | 0.12 | 0.11 | 0.5 | 0.41 | 0.55 | 1.05 | 0.97 | 1.23 | 1.24 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 57.39 | 57.32 | 57.32 | 57.32 | 57.32 | 57 | 57 | 57 | 57 | 57 |
| FII | 0.19 | 0.67 | 0.32 | 0.32 | 0.81 | 0.29 | 0.32 | 0.15 | 0.02 | 1.79 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.52 |
| Public | 42.41 | 41.99 | 42.35 | 42.35 | 41.86 | 42.71 | 42.68 | 42.84 | 42.97 | 40.69 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 7.22 | 7.22 | 7.22 | 7.22 | 7.22 | 7.18 | 7.18 | 7.18 | 7.18 | 7.18 |
| FII | 0.02 | 0.08 | 0.04 | 0.04 | 0.1 | 0.04 | 0.04 | 0.02 | 0 | 0.23 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 |
| Public | 5.33 | 5.29 | 5.33 | 5.33 | 5.27 | 5.38 | 5.37 | 5.4 | 5.41 | 5.12 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12.58 | 12.59 | 12.59 | 12.59 | 12.59 | 12.59 | 12.59 | 12.59 | 12.59 | 12.59 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +15% | +9% | +10% | +8% |
| Operating Profit CAGR | +19% | +12% | +15% | +2% |
| PAT CAGR | +153% | +8% | +4% | -6% |
| Share Price CAGR | +156% | +28% | +3% | +1% |
| ROE Average | +4% | +2% | +4% | +15% |
| ROCE Average | +7% | +5% | +6% | +17% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 57.39 | 57.32 | 57.32 | 57.32 | 57.32 | 57 | 57 | 57 | 57 | 57 |
| FII | 0.19 | 0.67 | 0.32 | 0.32 | 0.81 | 0.29 | 0.32 | 0.15 | 0.02 | 1.79 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.52 |
| Public | 42.41 | 41.99 | 42.35 | 42.35 | 41.86 | 42.71 | 42.68 | 42.84 | 42.97 | 40.69 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 7.22 | 7.22 | 7.22 | 7.22 | 7.22 | 7.18 | 7.18 | 7.18 | 7.18 | 7.18 |
| FII | 0.02 | 0.08 | 0.04 | 0.04 | 0.1 | 0.04 | 0.04 | 0.02 | 0 | 0.23 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 |
| Public | 5.33 | 5.29 | 5.33 | 5.33 | 5.27 | 5.38 | 5.37 | 5.4 | 5.41 | 5.12 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12.58 | 12.59 | 12.59 | 12.59 | 12.59 | 12.59 | 12.59 | 12.59 | 12.59 | 12.59 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.